Summary Significant Event Operating Highlights in Q2/2024 Q2/23 Q2/24 Change +/(-) 1H/23 1H/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 299 376 26% 563 716 27% Gross Profit 192 250 30% 361 476
Limited 4 MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2020 3. Financial highlights (based on Thai FRS) Q1 2020 Financial Position Summary as of 31 March 2020 compared to Q1 2019: Note
operating results Details as follows: Performance summary (Summary Table) Unit: Million Baht Q2/2019 Q2/2020 %change 6M/2019 6M/2020 % change Revenue from contracts with customers 91.8 87.0 -5.2% 181.7 184.1
regard, such system shall serve accurately and thoroughly, including verification and safety of such stored things, and shall be at least in accordance with Clause 14; (13) having additional system for the
shall serve accurately and thoroughly, including verification and safety of such stored things, and shall be at least in accordance with Clause 14; (13) having additional system for the following specific
documentation as prescribed in Clause 6 together with the following documents: (1) summary of the essences of the draft agreement on income guarantee; (2) information relating to the income guarantor who is a
accounts. The Company’s Board of Directors has considered and resolved that the price of the investment disposition was appropriate. Summary of SBITO’s financial statements as of September 30, 2017 are as
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company